Vertex Pharmaceuticals Incorporated | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (80)

Latest Posts

About This Stock More About This Stock
Biotech And Medtech Portfolio Notes On A Fed Day
Article By: Rod Raynovich
Wednesday, January 31, 2024 10:00 PM EST
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%
In this article: BDX, BSX, EW, PFE, SYK, TMO, QQQ, VRTX, IHI, XBI, ARKG
Read
Biotech And Healthcare Portfolio Playbook For December 2023/24
Article By: Rod Raynovich
Monday, November 27, 2023 12:47 PM EST
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January.
In this article: IBB, VRTX, XBI Also: LLY, PFE, ISRG, XLV, ABBV, MRK, REGN
Read
Biotech Sector: On The Verge Of Triumph Or Turmoil?
Article By: Tactical Investor
Friday, October 6, 2023 2:37 AM EST
In this article, we delve into the Biotech Sector, exploring its promises, potential pitfalls, and the questions that arise.
In this article: REGN, AMGN, BIIB, GILD, VRTX
Read
Gene Therapy Breakthroughs On The Horizon
Article By: Nelson Alves
Monday, August 21, 2023 3:00 PM EST
Vertex Pharmaceuticals and CRISPR Therapeutics, alongside bluebird bio, are penning a new chapter in the story of gene therapy for sickle cell disease.
In this article: VRTX, CRSP
Read
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
Article By: Rod Raynovich
Monday, April 3, 2023 1:14 PM EST
It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners.
In this article: REGN, VRTX, IBB Also: BMY, LLY, MRK, PFE, GILD, ABBV, XBI, XLV
Read

Latest Tweets for $VRTX

No tweets yet!

PARTNER HEADLINES